导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 36.66% | 97/1050 |
| 近一周 | -1.84% | 335/1104 |
| 近一月 | 3.09% | 15/1102 |
| 近一季 | -9.71% | 647/1092 |
| 近半年 | 6.96% | 289/1070 |
| 近一年 | 52.29% | 70/1018 |
| 近两年 | 122.92% | 141/926 |
| 近三年 | 64.25% | 181/834 |
| 成立以来 | 19.48% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
24.12% 5/1070 |
37.82% 275/1101 |
- - |
- - |
| 2025 | 33.12% 425/1065 |
-4.93% 985/1014 |
0.43% 655/1038 |
24.81% 449/1050 |
11.71% 35/1065 |
| 2024 | -6.88% 725/1011 |
-11.04% 799/960 |
-3.37% 539/983 |
8.99% 713/991 |
-0.61% 355/1011 |
| 2023 | -16.65% 587/952 |
5.57% 287/880 |
-9.28% 743/895 |
-10.13% 593/915 |
-3.16% 340/952 |
| 2022 | -45.79% 726/867 |
-27.47% 732/773 |
-2.54% 734/806 |
-8.57% 167/845 |
-16.12% 833/867 |
| 2021 | 10.31% 245/740 |
-4.08% 308/580 |
20.24% 160/659 |
-8.83% 474/704 |
4.91% 229/740 |
| 2020 | 56.43% 209/554 |
3.53% 89/419 |
24.53% 200/466 |
2.40% 396/517 |
18.48% 141/554 |
| 2019 | 40.76% 214/410 |
28.44% 465/1146 |
-4.70% 687/1228 |
12.73% 70/390 |
2.01% 380/410 |
| 2018 | -31.29% 235/349 |
- - |
-13.26% 679/990 |
-9.57% 736/1000 |
-10.97% 381/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源价值策略股票 VS. 东吴新产业精选股票A(580008) |